logo

SURF(Delisted)

Surface OncologyยทNASDAQ
--
--(--)

SURF Profile

Surface Oncology, Inc.

A clinical-stage immuno-oncology company that developing immunotherapies for the tumor microenvironment

--
--
04/19/2018
NASDAQ Stock Exchange
60
12-31
Common stock
50 Hampshire Street, 8th Floor, Cambridge, MA 02139
--
Surface Oncology, Inc., incorporated under the laws of Delaware in April 2014, is a clinical-stage immuno-oncology company focused on leveraging its expertise in biological pathways, or TMEs, critical to the immunosuppressive tumor microenvironment for the development of next-generation cancer therapies.